Diminished disease severity resulted from the administration of IL-10 in the NZM2410 mouse model of lupus [44], and more severe disease occurred in MRL/lpr mice on the IL-10 KO background and in B10 cell-deficient NZB/W mice [24], [45]. Here, IL10 is linked to systemic lupus erythematosus.